Gibson Dunn & Crutcher advised Spyre Therapeutics, Inc. on the offering, and Covington & Burling advised the underwriters. Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (NASDAQ:...
Spyre Therapeutics’ $200 Million Common Stock Offering
Zai Lab’s $200 Million Secondary Offering
Ropes & Gray represented Zai Lab Limited in the offering, while Simpson Thacher & Bartlett represented the underwriters. Zai Lab Limited (“Zai Lab” or the “Company”)...
Summit Midstream Corporation’s Acquisition of Tall Oak Midstream III
Locke Lord advised Summit Midstream Corporation on the transaction, Kirkland & Ellis advised Tall Oak Midstream III and Tailwater Capital, and Gibson, Dunn & Crutcher advised...
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
OneStream’s $490 Million IPO
Wilson Sonsini Goodrich & Rosati advised OneStream on the offering, Jones Day advised Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Latham & Watkins advised the...
Planet Fitness’ $800 Million Notes Offering
Ropes & Gray has advised Planet Fitness, while White & Case has advised Guggenheim Securities, LLC, as structuring agent, on the offering. Planet Fitness announced a...
UroGen Pharma’s Follow-on Public Offering
Gornitzky represented the underwriters, led by TD Cowen and Guggenheim Securities on the offering. UroGen Pharma Ltd. secured a USD 107.5 million follow-on public offering of...
ProKidney’s Upsized Public Offering and Registered Direct Offering
Davis Polk & Wardwell advised ProKidney, while Paul Hastings advised Jefferies, J.P. Morgan, and Guggenheim Securities, as joint book-running managers, in the transaction. ProKidney Corp. (Nasdaq:...
Noble Corporation’s Acquisition of Diamond Offshore Drilling
Paul Weiss Rifkind Wharton & Garrison is advising Noble Corporation plc on the transaction, Kirkland & Ellis is advising Diamond Offshore Drilling, Inc. and Covington &...
SES’s $3.1 Billion Acquisition of Intelsat
Skadden and Elvinger Hoss Prussen represented Intelsat in the transaction, and Gibson, Dunn & Crutcher and Hogan Lovells represented SES. Debevoise & Plimpton advised Guggenheim Securities...
Voyager Therapeutics’ $100 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
Celldex Therapeutics’ $230.5 Million Common Stock Offering
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...